Quadrant Capital Group LLC Sells 225 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Quadrant Capital Group LLC lessened its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 2.0% in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 11,247 shares of the healthcare conglomerate’s stock after selling 225 shares during the quarter. Quadrant Capital Group LLC’s holdings in UnitedHealth Group were worth $5,689,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also bought and sold shares of the company. NewSquare Capital LLC acquired a new position in UnitedHealth Group in the fourth quarter valued at about $25,000. Hurley Capital LLC acquired a new stake in shares of UnitedHealth Group during the 4th quarter worth approximately $28,000. AlphaMark Advisors LLC bought a new stake in UnitedHealth Group during the fourth quarter worth $30,000. Promus Capital LLC bought a new position in shares of UnitedHealth Group in the 4th quarter valued at $32,000. Finally, Pillar Financial Advisors LLC acquired a new stake in UnitedHealth Group in the fourth quarter valued at about $40,000. Institutional investors and hedge funds own 87.86% of the company’s stock.

Analyst Upgrades and Downgrades

A number of research analysts have recently commented on the stock. KeyCorp reissued an “overweight” rating and issued a $650.00 target price on shares of UnitedHealth Group in a report on Friday, January 17th. StockNews.com upgraded shares of UnitedHealth Group from a “hold” rating to a “buy” rating in a research report on Thursday, January 23rd. Barclays dropped their price target on UnitedHealth Group from $655.00 to $642.00 and set an “overweight” rating for the company in a research note on Friday, January 17th. Truist Financial dropped their target price on UnitedHealth Group from $625.00 to $610.00 and set a “buy” rating for the company in a research report on Monday, January 6th. Finally, Wells Fargo & Company lowered their price objective on UnitedHealth Group from $694.00 to $660.00 and set an “overweight” rating for the company in a research note on Tuesday, January 28th. Twenty investment analysts have rated the stock with a buy rating and two have assigned a strong buy rating to the stock. According to data from MarketBeat, the company has an average rating of “Buy” and a consensus target price of $629.32.

UnitedHealth Group Trading Down 2.9 %

Shares of UNH stock opened at $524.94 on Friday. The company has a market cap of $480.17 billion, a P/E ratio of 33.87, a PEG ratio of 1.37 and a beta of 0.62. UnitedHealth Group Incorporated has a fifty-two week low of $436.38 and a fifty-two week high of $630.73. The stock has a 50 day simple moving average of $509.24 and a two-hundred day simple moving average of $542.12. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.83.

UnitedHealth Group (NYSE:UNH) last issued its earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share (EPS) for the quarter, topping the consensus estimate of $6.74 by $0.07. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The business had revenue of $100.81 billion for the quarter, compared to analyst estimates of $101.60 billion. During the same period in the prior year, the firm earned $5.83 earnings per share. UnitedHealth Group’s revenue was up 6.8% on a year-over-year basis. Research analysts forecast that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, March 18th. Stockholders of record on Monday, March 10th were issued a dividend of $2.10 per share. The ex-dividend date was Monday, March 10th. This represents a $8.40 annualized dividend and a dividend yield of 1.60%. UnitedHealth Group’s dividend payout ratio is 54.19%.

Insider Buying and Selling

In related news, Director Timothy Patrick Flynn purchased 1,000 shares of the business’s stock in a transaction on Friday, January 17th. The stock was acquired at an average price of $511.57 per share, for a total transaction of $511,570.00. Following the purchase, the director now owns 4,500 shares of the company’s stock, valued at approximately $2,302,065. This trade represents a 28.57 % increase in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. 0.33% of the stock is owned by company insiders.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.